Patents and the global diffusion of new drugs

American Economic Review

Volumn 106, Issue 1, 2016, Pages 136-164

  Cockburn, Iain M ^a   Lanjouw, Jean O ^b   Schankerman, Mark ^c  

^a BOSTON UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

DRUG APPROVAL; ECONOMICS; GLOBAL HEALTH; GROSS NATIONAL PRODUCT; HEALTH CARE POLICY; HUMAN; INCOME; MASS COMMUNICATION; PATENT;

DIFFUSION OF INNOVATION; DRUG APPROVAL; DRUGS, INVESTIGATIONAL; GLOBAL HEALTH; GROSS DOMESTIC PRODUCT; HEALTH POLICY; HUMANS; INCOME; PATENTS AS TOPIC;

EID: 85012305725     PISSN: 00028282     EISSN: None     Source Type: Journal    
DOI: 10.1257/aer.20141482     Document Type: Article

References (41)

1. Acemoglu, Daron, and Joshua Linn. 2004. "Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry." Quarterly Journal of Economics 119 (3): 1049-90.
2. Arrow, Kenneth. 1962. "Economic Welfare and the Allocation of Resources for Invention." In The Rate and Direction of Inventive Activity: Economic and Social Factors, edited by Richard Nelson, 609-26. Princeton: Princeton University Press.
3. Bloom, Nicholas, and John Van Reenen. 1998. "Regulating Drug Prices: Where Do We Go from Here?" Fiscal Studies 19 (3): 321-42.
4. Branstetter, Lee G., Raymond Fisman, and C. Fritz Foley. 2006. "Do Stronger Intellectual Property Rights Increase International Technology Transfer? Empirical Evidence from U.S. Firm-Level Panel Data." Quarterly Journal of Economics 121 (1): 321-49.
5. Brekke, Kurt R., Astrid L. Grasdal, and Tor Helge Holmas. 2009. "Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?" European Economic Review 53 (2): 170-85.
6. Bresnahan, Timothy F., and Peter C. Reiss. 1987. "Do Entry Conditions Vary across Markets?" Brookings Papers on Economic Activity 18 (3): 833-82.
7. Budish, Eric, Benjamin N. Roin, and Heidi Williams. 2013. "Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials." National Bureau of Economic Research Working Paper 19430.
8. Chaudhuri, Shubham, Pinelopi K. Goldberg, and Panle Jia. 2006. "Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India." American Economic Review 96 (5): 1477-1514.
9. Cockburn, Iain M., Jean O. Lanjouw, and Mark Schankerman. 2016. "Patents and the Global Diffusion of New Drugs: Dataset." American Economic Review. http://dx.doi.org/10.1257/aer.20141482.
10. Collard-Wexler, Allan. 2013. "Demand Fluctuations in the Ready-Mix Concrete Industry." Econometrica 81 (3): 1003-37.
11. Danzon, Patricia M., Y. Richard Wang, and Liang Wang. 2005. "The Impact of Price Regulation on the Launch Delay of New Drugs-Evidence from Twenty-five Major Markets in the 1990s." Health Economics 14 (3): 269-92.
12. Delgado, Mercedes, Margaret Kyle, and Anita M. McGahan. 2013. "Intellectual Property Protection and the Geography of Trade." Journal of Industrial Economics 61 (3): 733-62.
13. Dranove, David, and David Meltzer. 1994. "Do Important Drugs Reach the Market Sooner?" RAND Journal of Economics 25 (3): 402-23.
14. Dubois, Pierre, Olivier de Mouzon, Fiona Scott-Morton, and Paul Seabright. 2015. "Market Size and Pharmaceutical Innovation." RAND Journal of Economics 46 (4): 844-71.
15. Duggan, Mark, Craig Garthwaite, and Aparajita Goyal. 2016. "The Market Impacts of Pharmaceutical Product Patents in Developing Countries: Evidence from India." American Economic Review 106 (1): 99-135
16. Ericson, Richard, and Ariel Pakes. 1995. "Markov-Perfect Industry Dynamics: A Framework for Empirical Work." Review of Economic Studies 62 (1): 53-82.
17. Galasso, Alberto, and Mark Schankerman. 2015. "Patents and Cumulative Innovation: Causal Evidence from the Courts." Quarterly Journal of Economics 130 (1): 317-69.
18. Ganslandt, Mattias, and Keith E. Maskus. 2004. "Parallel Imports and the Pricing of Pharmaceutical Products: Evidence from the European Union." Journal of Health Economics 23 (5): 1035-57.
19. Ginarte, Juan C., and Walter G. Park. 1997. "Determinants of Patent Rights: A Cross-National Study." Research Policy 26 (3): 283-301.
20. Grabowski, Henry G., and Margaret Kyle. 2007. "Generic Competition and Market Exclusivity Periods in Pharmaceuticals." Managerial and Decision Economics 28 (4-5): 491-502.
21. Griliches, Zvi. 1957. "Hybrid Corn: An Exploration in the Economics of Technological Change." Econometrica 25 (4): 501-22.
22. Grossman, Gene M., and Edwin L. C. Lai. 2004. "International Protection of Intellectual Property." American Economic Review 94 (5): 1635-53.
23. Holmes, Thomas J. 2011. "The Diffusion of Wal-Mart and Economies of Density." Econometrica 79 (1): 253-302.
24. Jacobzone, Stéphane. 2000. "Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals." Organization for Economic Co-operation and Development Labour Market and Social Policy Occasional Paper 40.
25. Kremer, Michael. 1998. "Patent Buyouts: A Mechanism for Encouraging Innovation." Quarterly Journal of Economics 113 (4): 1137-67.
26. Kremer, Michael. 2002. "Pharmaceuticals and the Developing World." Journal of Economic Perspectives 16 (4): 67-90.
27. Kyle, Margaret K. 2006. "The Role of Firm Characteristics in Pharmaceutical Product Launches." RAND Journal of Economics 37 (3): 602-18.
28. Kyle, Margaret K. 2007. "Pharmaceutical Price Controls and Entry Strategies." Review of Economics and Statistics 89 (1): 88-99.
29. Kyle, Margaret K., and Anita M. McGahan. 2012. "Investments in Pharmaceuticals before and after TRIPS." Review of Economics and Statistics 94 (4): 1157-72.
30. Kyle, Margaret, and Yi Qian. 2014. "Intellectual Property Rights and Access to Innovation: Evidence from TRIPS." National Bureau of Economic Research Working Paper 20799.
31. Lanjouw, Jean O., and Iain M. Cockburn. 2001. "New Pills for Poor People? Empirical Evidence after GATT." World Development 29 (2): 265-89.
32. Lillard, Lee A. 1993. "Simultaneous Equations for Hazards: Marriage Duration and Fertility Timing." Journal of Econometrics 56 (1-2): 189-217.
33. Moser, Petra. 2005. "How Do Patent Laws Influence Innovation? Evidence from Nineteenth-Century World's Fairs." American Economic Review 95 (4): 1214-36.
34. Park, Walter G. 2008. "International Patent Protection: 1960-2005." Research Policy 37 (4): 761-66.
35. Qian, Yi. 2007. "Do National Patent Laws Stimulate Domestic Innovation in a Global Patenting Environment? A Cross-Country Analysis of Pharmaceutical Patent Protection, 1978-2002." Review of Economics and Statistics 89 (3): 436-53.
36. Ridley, David M., Henry G. Grabowski, and Jeffrey L. Moe. 2006. "Developing Drugs for Developing Countries." Health Affairs 25 (2): 313-324.
37. Rivers, Douglas, and Quang H. Vuong. 1988. "Limited Information Estimators and Exogeneity Tests for Simultaneous Probit Models." Journal of Econometrics 39 (3): 347-66.
38. Sakakibara, Mariko, and Lee Branstetter. 2001. "Do Stronger Patents Induce More Innovation? Evidence from the 1988 Japanese Patent Law Reforms." RAND Journal of Economics 32 (1): 77-100.
39. Scott Morton, Fiona M. 1999. "Entry Decisions in the Generic Pharmaceutical Industry." RAND Journal of Economics 30 (3): 421-40.
40. Sell, Susan K. 2003. Private Power, Public Law: the Globalization of Intellectual Property. Cambridge, UK: Cambridge University Press.
41. Williams, Heidi L. 2013. "Intellectual Property Rights and Innovation: Evidence from the Human Genome." Journal of Political Economy 121 (1): 1-27.